Navigation Links
ICON Medical Imaging Launches New Service to Boost Reliability of Cardiology Studies
Date:8/11/2008

First Commercial Imaging Lab to Offer Quantitative Coronary Angiographic

Analysis With Integrated eCRF

DUBLIN, August 11 /PRNewswire-FirstCall/ -- ICON plc (NASDAQ: ICLR; ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that its Medical Imaging division has become the first commercial imaging core laboratory to offer Quantitative Coronary Angiographic (QCA) analysis with an integrated electronic Case Report Form (eCRF).

This new service has been made possible through the integration of QCAPlus, a leading QCA application from Sanders Data Systems, with an eCRF within ICON Medical Imaging's proprietary Medical Image Review and Analysis (MIRA(TM)) system. The integration of QCAPlus adds to the existing visualisation, analysis and project management applications currently available through MIRA(TM).

"Clinical trials incorporating QCA have made a significant impact in cardiovascular drug and device development," commented Jonathan Goldman MD, Chief Medical Officer, ICON Medical Imaging. "Building QCA capabilities into MIRA(TM) represents the latest in a series of innovations designed to boost the integrity and reproducibility of clinical trial data, and enhances our leadership in the field of imaging within clinical research."

Coronary angiography is the gold standard for the diagnosis of obstructive coronary artery disease. The use of quantitative analysis for angiographic interpretation in clinical studies reduces variability and enables findings to be statistically categorised, leading to more reliable study results. The complexity of capturing angiographic analyses in a clinical trials database inspired the integration of QCAPlus with ICON's MIRA(TM) system. The new integrated system enables quantitative measurements and qualitative interpretations to be captured in a single electronic case report form i
'/>"/>

SOURCE ICON plc
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. AEterna Zentaris completes management team with the appointment of Chief Medical Officer
2. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. Pathway Medical Technologies Adds Joe Rafferty as VP, Sales, and Moves To Larger Facility to Accommodate Rapid Growth
5. BioMS Medical announces its intention to renew a normal course issuer bid
6. Dr. Amit Dhawan Promoted to Medical Director for The Mattson Jack Group
7. ATS Medical Expands Open Pivot Heart Valve Offerings
8. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
9. Globus Medical Announces Record 2nd Quarter 2007 Results
10. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
11. China Medical Technologies Reports First Quarter Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., , REYKJAVIK, Iceland, No...s, Inc. (Nasdaq: DCGN ) today announced that it ha...t trading in the company,s common stock will be,su...will be filed with the,Securities and Exchange Com...rom listing on Nasdaq, unless the company files an...
(Date:11/24/2009)..., , SAN MATEO, Calif., Nov. 24 /PRNewsw..., a biopharmaceutical company focused on developin...ies, announced today that Anthony DiTonno, Preside...esent at the 21st Annual Piper Jaffray Health Care...New York Palace Hotel in New York, New York. ,...
(Date:11/24/2009)..., , TSX VENTURE: HTL , TORONTO, Nov. ...TSX-V: HTL), formerly Calotto Capital Inc., a lead...ents for the stem cell research and fertility clin...al results for the third quarter ended September 3...ue was $1.46 million compared with $1.43 million i...
(Date:11/24/2009)... Program Connects Customer...amples Collected with DNA Genotek Products , ..., 2009 -- DNA Genotek , a leading provider of pro...ion and preparation, today announced its new globa...enhancements for DNA Genotek,s partner community a...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...(Nasdaq: PARS ) announced today that it has ente..., Reperio Pharmaceuticals Ltd. (Reperio) for the s...lated to the compound known as PRS-639,058 and som...noids are synthetic compounds which belong to the ...y fewer of the undesired psychotropic and cardiova...
...nologies, Inc. ("Senesco" or the "Company") (NYSE...ts for the three months ended December 31, 2008. ...ember 31, 2008 was $1,624,341, or $0.09 per share,...er share, for the three month period ended Decembe...ly the result of an increase in non-cash expenses ...
...recruitment events will be held on the nation,s co...ood, CO (Vocus) February 18, 2009 -- BioSpace.com,...ife science careers and industry resources, will h...r. These annual, networking opportunities attract ...eekers within the life sciences., , , , ,Biotech B...
Other Biology Technology:Pharmos Announces Agreement to Sell Certain CB2 Selective Agonists 2Pharmos Announces Agreement to Sell Certain CB2 Selective Agonists 3Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 2Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 3Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 4Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 5Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 6Senesco Technologies Reports Second Quarter Fiscal 2009 Financial Results 7BioSpace.com Launches a New Season of Industry Career Fairs 2
(Date:11/25/2009)...e California Institute of Technology (Caltech) hav...ehavior in the fruit fly, Drosophila melanogaster...e relationship between the neurotransmitter dopami...DHD), are described in the December issue of the j...ns only about 20,000 neurons and has long been con...
(Date:11/25/2009)... easy lives. In addition to mammalian immune syste...s called bacteriophages, viruses that kill half th...cteria and another class of microorganisms called ...such as deep-sea volcanic vents) manage just fine,...efense system that helps protect them from many vi...
(Date:11/25/2009)... Cell Death Research Laboratory in the University ... the prestigious Johnson & Johnson Focused Funding...in cell damage in Parkinson,s disease. The award, ...t of innovation and excellence in science, was ann...his month at an event at the Hyatt Regency Hotel i...
Breaking Biology News(10 mins):Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Armed Forces Retirement Home Selects Millenniums Pharmacy Services 50586 1Armed Forces Retirement Home Selects Millenniums Pharmacy Services 50586 2TrinityCare Senior Living Inc Information to be Available Through Standard 26 Poors Market Access Program 50582 1TrinityCare Senior Living Inc Information to be Available Through Standard 26 Poors Market Access Program 50582 2The Pennsylvania Breast Cancer Coalition Seeks Breast Cancer Survivors Throughout Pennsylvania 50578 1The Pennsylvania Breast Cancer Coalition Seeks Breast Cancer Survivors Throughout Pennsylvania 50578 2
...and construction can be significantly improved to ...help better resist high winds and hurricanes in re...chitecture professor Rima Taher, PhD. Taher, who ...e New Jersey School of Architecture. Courses taugh...uakes with guidelines and recommendations for bett...
... . Barcelona, Spain: For the first time in the...an embryonic stem cells (hESCs) from a single cell...h annual conference of the European Society of Hum...day 9 July). Dr. Hilde Van de Velde, from the Vrij...aid that their research meant that it might be pos...
...,Bulletin Board: BMRX), today announced that it ha...competitor, Sequiam Corporation. The company also,... those assets into the,company,s technology portfo...of which already are being sold under the company,...those assets is 44 Shares of Preferred,Stock plus ...
Other Biology News:NJIT architect professor advocates best-building practices for high wind regions 2Human embryonic stem cells developed from 4-cell embryo; world first may lessen ethical concerns 2Human embryonic stem cells developed from 4-cell embryo; world first may lessen ethical concerns 3Human embryonic stem cells developed from 4-cell embryo; world first may lessen ethical concerns 4bioMETRX, Inc. Completes Sequiam Asset Purchase 2
Mouse Anti-Bovine collagen type IX Monoclonal Antibody, Unconjugated from Developmental Studies Hybridoma Bank
Goat Anti-Mouse Nodal Polyclonal Antibody, Unconjugated from R&D Systems
Rat Anti-Mouse MMP-24 (MT5-MMP) Monoclonal Antibody, Unconjugated, Clone 143908 from R&D Systems
Prostaglandin E2 Luminex Standard from Cayman Chemical
Biology Products: